Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Filter
  • 1-10 of  6,630 results for ""Cerebrospinal fluid""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Proteome profiling of cerebrospinal fluid using machine learning shows a unique protein signature associated with APOE4 genotype.

Subjects: Apolipoprotein E4*/Apolipoprotein E4*/Apolipoprotein E4*/genetics ; Apolipoprotein E4*/Apolipoprotein E4*/Apolipoprotein E4*/cerebrospinal fluid ; Machine Learning*

  • Source: Aging cell [Aging Cell] 2025 Apr; Vol. 24 (4), pp. e14439. Date of Electronic Publication: 2024 Dec 25.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101130839 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cerebrospinal fluid proteome profiling across the Alzheimer's disease continuum: a step towards solving the equation for 'X'.

  • Authors : Weiner S; Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, University of Gothenburg, Mölndal, Sweden. .; Sauer M

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology ; Proteome*/Proteome*/Proteome*/metabolism

  • Source: Molecular neurodegeneration [Mol Neurodegener] 2025 May 06; Vol. 20 (1), pp. 52. Date of Electronic Publication: 2025 May 06.Publisher: BioMed Central Country of Publication: England NLM ID: 101266600 Publication Model: Electronic Cited Medium: Internet ISSN: 1750-1326

Record details

×
Academic Journal

Associations of Cerebrospinal Fluid Orexin-A, Alzheimer Disease Biomarkers, and Cognitive Performance.

  • Authors : Lu R; Division of Biostatistics, Washington University School of Medicine, St Louis, Missouri, USA.; Shah K

Subjects: Orexins*/Orexins*/Orexins*/cerebrospinal fluid ; Orexins*/Orexins*/Orexins*/blood ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2025 Apr; Vol. 12 (4), pp. 780-791. Date of Electronic Publication: 2025 Feb 17.Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

Record details

×
Academic Journal

Evaluation of cerebrospinal fluid levels of VAMP-2 and SNAP-25 in a dementia with Lewy bodies clinical cohort stratified by Alzheimer's pathophysiological biomarkers.

  • Authors : González AC; Sant Pau Memory Unit, Institut de Recerca Sant Pau, Universitat Autonoma de Barcelona, c/Sant Quintí 77, Barcelona, 08041, Spain.; Network Center for Biomedical Research in Neurodegenerative Diseases (CIBERNED), Madrid, Spain.

Subjects: Synaptosomal-Associated Protein 25*/Synaptosomal-Associated Protein 25*/Synaptosomal-Associated Protein 25*/cerebrospinal fluid ; Lewy Body Disease*/Lewy Body Disease*/Lewy Body Disease*/cerebrospinal fluid ; Lewy Body Disease*/Lewy Body Disease*/Lewy Body Disease*/psychology

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 Feb 24; Vol. 17 (1), pp. 51. Date of Electronic Publication: 2025 Feb 24.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

β-synuclein in cerebrospinal fluid as a potential biomarker for distinguishing human prion diseases from Alzheimer's and Parkinson's disease.

  • Authors : Xu B; National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Disease, NHC Key Laboratory of Medical Virology and Viral Diseases, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.; Xiao K

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/diagnosis ; Parkinson Disease*/Parkinson Disease*/Parkinson Disease*/cerebrospinal fluid

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 Feb 07; Vol. 17 (1), pp. 39. Date of Electronic Publication: 2025 Feb 07.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Cerebrospinal fluid β2-microglobulin promotes the tau pathology through microglia-astrocyte communication in Alzheimer's disease.

  • Authors : Sheng Z; Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, No.1 Youyi Road, Yuzhong District, Chongqing, 400016, China.; Key Laboratory of Major Brain Disease and Aging Research (Ministry of Education), Chongqing Medical University, Chongqing, 400016, China.

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology ; tau Proteins*/tau Proteins*/tau Proteins*/cerebrospinal fluid

  • Source: Alzheimer's research & therapy [Alzheimers Res Ther] 2025 Jan 02; Vol. 17 (1), pp. 2. Date of Electronic Publication: 2025 Jan 02.Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 101511643 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study.

  • Authors : Guillén N; Alzheimer's Disease and Other Cognitive Disorders Unit, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic de Barcelona, Carrer Villarroel, 170, 08036, Barcelona, Spain.; Contador J

Subjects: Amyloid beta-Peptides*/Amyloid beta-Peptides*/Amyloid beta-Peptides*/cerebrospinal fluid ; tau Proteins*/tau Proteins*/tau Proteins*/cerebrospinal fluid ; Positron-Emission Tomography*/Positron-Emission Tomography*/Positron-Emission Tomography*/standards

  • Source: European archives of psychiatry and clinical neuroscience [Eur Arch Psychiatry Clin Neurosci] 2025 Feb; Vol. 275 (1), pp. 257-266. Date of Electronic Publication: 2023 Oct 28.Publisher: Springer International Country of Publication: Germany NLM ID: 9103030 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Head-to-Head Comparison of Aptamer- and Antibody-Based Proteomic Platforms in Human Cerebrospinal Fluid Samples from a Real-World Memory Clinic Cohort.

  • Authors : Puerta R; Ace Alzheimer Center Barcelona, Universitat Internacional de Catalunya, 08029 Barcelona, Spain.; PhD Program in Biotecnology, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain.

Subjects: Proteomics*/Proteomics*/Proteomics*/methods ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Aptamers, Nucleotide*

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Dec 31; Vol. 26 (1). Date of Electronic Publication: 2024 Dec 31.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

Record details

×
Academic Journal

Plasma exchange with albumin replacement for Alzheimer's disease treatment induced changes in serum and cerebrospinal fluid inflammatory mediator levels.

  • Authors : Gonzalo R; Grifols Scientific Innovation Office, Avinguda de la Generalitat 152-158, Sant Cugat del Vallès, 08174, Barcelona, Spain.; Minguet C

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/blood

  • Source: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2024 Dec; Vol. 11 (12), pp. 3280-3291. Date of Electronic Publication: 2024 Oct 30.Publisher: Wiley Periodicals, Inc on behalf of American Neurological Association Country of Publication: United States NLM ID: 101623278 Publication Model:

Record details

×
Academic Journal

Phosphorylated tau in cerebrospinal fluid-derived extracellular vesicles in Alzheimer's disease: a pilot study.

  • Authors : Sattarov R; Clinical Memory Research Unit, Department of Clinical Sciences Malmö, Lund University, Lund, Sweden. .; Havers M

Subjects: Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/cerebrospinal fluid ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/metabolism ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/pathology

  • Source: Scientific reports [Sci Rep] 2024 Oct 25; Vol. 14 (1), pp. 25419. Date of Electronic Publication: 2024 Oct 25.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  6,630 results for ""Cerebrospinal fluid""